首页> 外文期刊>Rheumatology International >A case of AA amyloidosis associated with rheumatoid arthritis effectively treated with Infliximab
【24h】

A case of AA amyloidosis associated with rheumatoid arthritis effectively treated with Infliximab

机译:英夫利昔单抗有效治疗类风湿性关节炎相关的AA淀粉样变性

获取原文
获取原文并翻译 | 示例
           

摘要

We report the case of a 55-year-old Japanese woman with reactive AA amyloidosis associated with rheumatoid arthritis, in which inflammatory disease was completely suppressed with infliximab. Nephrotic syndrome was observed and renal biopsy specimens revealed amyloidosis deposits. Treatment with infliximab normalized the serum amyloid A (SAA) protein level, and subsequently nephritic syndrome disappeared and her creatinine clearance improved. Serial gastrointestinal biopsy specimens showed marked lasting regression of amyloid deposits. Thus treatment with infliximab represents an important therapeutic strategy for AA amyloidosis associated with RA.
机译:我们报道了一名55岁的日本妇女与类风湿性关节炎相关的反应性AA淀粉样变性病的病例,其中英夫利昔单抗完全抑制了炎症性疾病。观察到肾病综合征,肾活检标本显示淀粉样变性病沉积物。英夫利昔单抗治疗可使血清淀粉样蛋白A(SAA)蛋白质水平正常化,随后肾病综合征消失且肌酐清除率提高。胃肠道活检标本显示淀粉样沉积物有明显的持久消退。因此,英夫利昔单抗的治疗代表了与RA相关的AA淀粉样变性的重要治疗策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号